Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... The Lancet 399 (10323), 437-446, 2022 | 1134 | 2022 |
Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... Jama 328 (16), 1604-1615, 2022 | 676 | 2022 |
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa F Abdullah, J Myers, D Basu, G Tintinger, V Ueckermann, M Mathebula, ... International journal of infectious diseases 116, 38-42, 2022 | 464 | 2022 |
Population immunity and Covid-19 severity with Omicron variant in South Africa SA Madhi, G Kwatra, JE Myers, W Jassat, N Dhar, CK Mukendi, AJ Nana, ... New England Journal of Medicine 386 (14), 1314-1326, 2022 | 397 | 2022 |
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions K Dheda, T Perumal, H Moultrie, R Perumal, A Esmail, AJ Scott, ... The Lancet Respiratory Medicine 10 (6), 603-622, 2022 | 224 | 2022 |
Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B. 1.1. 529) variant wave in South Africa: a multicentre observational study J Cloete, A Kruger, M Masha, NM du Plessis, D Mawela, M Tshukudu, ... The Lancet Child & Adolescent Health 6 (5), 294-302, 2022 | 222 | 2022 |
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections A Sigal, R Milo, W Jassat Nature Reviews Immunology 22 (5), 267-269, 2022 | 205 | 2022 |
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study W Jassat, SSA Karim, C Mudara, R Welch, L Ozougwu, MJ Groome, ... The Lancet Global Health 10 (7), e961-e969, 2022 | 194 | 2022 |
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study W Jassat, C Cohen, S Tempia, M Masha, S Goldstein, T Kufa, ... The Lancet HIV 8 (9), e554-e567, 2021 | 187 | 2021 |
Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study W Jassat, C Mudara, L Ozougwu, S Tempia, L Blumberg, MA Davies, ... The Lancet Global Health 9 (9), e1216-e1225, 2021 | 170 | 2021 |
Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa MA Davies, R Kassanjee, P Rousseau, E Morden, L Johnson, W Solomon, ... Tropical Medicine & International Health 27 (6), 564-573, 2022 | 155 | 2022 |
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform … S Bertagnolio, SS Thwin, R Silva, S Nagarajan, W Jassat, R Fowler, ... The Lancet HIV 9 (7), e486-e495, 2022 | 153 | 2022 |
SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020–March 2021 J Kleynhans, S Tempia, N Wolter, A von Gottberg, JN Bhiman, A Buys, ... Emerging infectious diseases 27 (12), 3020, 2021 | 105 | 2021 |
A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... MedRxiv, 2022 | 89 | 2022 |
Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study M Dryden, C Mudara, C Vika, L Blumberg, N Mayet, C Cohen, S Tempia, ... The Lancet Global Health 10 (9), e1247-e1256, 2022 | 87 | 2022 |
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA. 4 and BA. 5 compared with previous waves in the Western Cape Province … MA Davies, E Morden, P Rousseau, J Arendse, JL Bam, L Boloko, ... International Journal of Infectious Diseases 127, 63-68, 2023 | 83 | 2023 |
Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages compared to BA. 1 and Delta in South Africa N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, MJ Groome, ... Nature communications 13 (1), 5860, 2022 | 81 | 2022 |
Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study LG Bekker, N Garrett, A Goga, L Fairall, T Reddy, N Yende-Zuma, ... The Lancet 399 (10330), 1141-1153, 2022 | 81 | 2022 |
Clinical severity of omicron lineage BA. 2 infection compared with BA. 1 infection in South Africa N Wolter, W Jassat, A von Gottberg, C Cohen The Lancet 400 (10346), 93-96, 2022 | 69 | 2022 |
A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants W Jassat, C Mudara, C Vika, R Welch, T Arendse, M Dryden, L Blumberg, ... International Journal of Infectious Diseases 128, 102-111, 2023 | 58 | 2023 |